HER2/neu
Hunk is required for HER2/neu induced mammary tumorigenesis
15
Suppression of Her2/Neu mammary tumor development in mda- 7/IL-24 transgenic mice
12
Study of prevalence of prognostic and predictive immunohistochemical markers er, PR and Her2/neu and their correlation with age in cases of female carcinoma breast in Bihar (Northern India)
5
Expression of anaplastic lymphokinase and HER2/neu immunostaining in patients with breast carcinoma
6
Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience
9
Expression of Her2/neu receptor in carcinoma gallbladder correlates significantly with advanced tumor stage
6
Prognostic Implications of ER, PR and HER2/Neu Protein Expression in a Cohort of Breast Carcinoma
6
HER2/neu-directed therapy for biliary tract cancer
9
Interleukin 15 is required for immunosurveillance and immunoprevention of HER2/neu driven mammary carcinogenesis
13
Notch promotes recurrence of dormant tumor cells following HER2/neu targeted therapy
14
Evaluation of Expression of Her2/neu in Gastric Cancer and Its Significance as a Prognostic Factor in Gastric Adenocarcinoma
163
Determining the Role of Autophagy in HER2/neu-Induced Mammary Tumor Dormancy and Recurrence
194
Role of HER2 / neu expression in colorectal carcinomas and its correlation with histological grades
143
Synthesis of Gemcitabine (C4 amide) [anti HER2/neu] Utilizing a UV Photoactivated Gemcitabine Intermediate: Cytotoxic Anti Neoplastic Activity against Chemotherapeutic Resistant Mammary Adenocarcinoma SKBr 3
23
HER2/neu immunohistochemical expression in gastric carcinoma
8
Clinical significance of Akt and HER2/neu overexpression in African American and Latina women with breast cancer
19
Original Article Immunohistochemical results of HER2/neu protein expression assessed by rabbit monoclonal antibodies SP3 and 4B5 in colorectal carcinomas
7
Prognostic relevance of HER2/neu in acute lymphoblastic leukemia and induction of NK cell reactivity against primary ALL blasts by trastuzumab
18
Evaluation of HER2/neu Expression in Carcinoma Cervix
160
Clinicopathological study of benign and malignant ovarian tumours and the role of HER2/neu and ER expression in these tumours
5